| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 37 |
| 1 | CARBOPLATIN | 36 |
| 2 | CYTARABINE | 33 |
| 3 | CYCLOPHOSPHAMIDE | 32 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 32 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 32 |
| 6 | ETOPOSIDE | 29 |
| 7 | DOXORUBICIN | 28 |
| 8 | GEMCITABINE HYDROCHLORIDE | 28 |
| 9 | OXALIPLATIN | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SHARK CARTILAGE | 1 | 0.0119 |
| 1 | LIFILEUCEL | 1 | 0.0035 |
| 2 | INTERLEUKIN-10 | 1 | 0.0028 |
| 3 | CARMUSTINE | 11 | 0.0023 |
| 4 | ROLAPITANT | 1 | 0.0019 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 13 | 0.0016 |
| 6 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 2 | 0.0014 |
| 7 | BLINATUMOMAB | 12 | 0.0011 |
| 8 | BENDAMUSTINE HYDROCHLORIDE | 9 | 0.0011 |
| 9 | NELARABINE | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 67 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 58 |
| 2 | Platinum-based Drug [EPC] | 58 |
| 3 | Kinase Inhibitor [EPC] | 55 |
| 4 | Alkylating Drug [EPC] | 44 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 6 | Topoisomerase Inhibitor [EPC] | 30 |
| 7 | Benzodiazepine [EPC] | 28 |
| 8 | Microtubule Inhibitor [EPC] | 28 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 1 | Alkaloid [EPC] | 13 | 0.0005 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 10 | 0.0005 |
| 3 | Radioligand Therapeutic Agent [EPC] | 6 | 0.0004 |
| 4 | Topoisomerase Inhibitor [EPC] | 30 | 0.0004 |
| 5 | Cannabinoid [EPC] | 3 | 0.0004 |
| 6 | Oxazolidinone Antibacterial [EPC] | 10 | 0.0003 |
| 7 | Estrogen Receptor Antagonist [EPC] | 9 | 0.0002 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 21 | 0.0002 |
| 9 | Platinum-based Drug [EPC] | 58 | 0.0002 |